Imerys Sa Stock Performance

IMYSF Stock  USD 27.00  0.00  0.00%   
The company retains a Market Volatility (i.e., Beta) of 0.61, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Imerys SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Imerys SA is expected to be smaller as well. At this point, Imerys SA has a negative expected return of -0.31%. Please make sure to check out Imerys SA's mean deviation, jensen alpha, as well as the relationship between the Jensen Alpha and day median price , to decide if Imerys SA performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Imerys SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow647.8 M
Total Cashflows From Investing Activities-309.6 M
  

Imerys SA Relative Risk vs. Return Landscape

If you would invest  3,401  in Imerys SA on October 2, 2025 and sell it today you would lose (701.00) from holding Imerys SA or give up 20.61% of portfolio value over 90 days. Imerys SA is currently producing negative expected returns and takes up 2.9141% volatility of returns over 90 trading days. Put another way, 26% of traded otc stocks are less volatile than Imerys, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Imerys SA is expected to under-perform the market. In addition to that, the company is 4.04 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Imerys SA Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Imerys SA's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Imerys SA, and traders can use it to determine the average amount a Imerys SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1069

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIMYSF
Based on monthly moving average Imerys SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Imerys SA by adding Imerys SA to a well-diversified portfolio.

Imerys SA Fundamentals Growth

Imerys OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Imerys SA, and Imerys SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Imerys OTC Stock performance.

About Imerys SA Performance

By analyzing Imerys SA's fundamental ratios, stakeholders can gain valuable insights into Imerys SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Imerys SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Imerys SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Imerys S.A. provides mineral-based specialty solutions for various industries worldwide. The company was incorporated in 1880 and is headquartered in Paris, France. Imerys Sa is traded on OTC Exchange in the United States.

Things to note about Imerys SA performance evaluation

Checking the ongoing alerts about Imerys SA for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Imerys SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Imerys SA generated a negative expected return over the last 90 days
About 70.0% of the company shares are owned by institutional investors
Evaluating Imerys SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Imerys SA's otc stock performance include:
  • Analyzing Imerys SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Imerys SA's stock is overvalued or undervalued compared to its peers.
  • Examining Imerys SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Imerys SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Imerys SA's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Imerys SA's otc stock. These opinions can provide insight into Imerys SA's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Imerys SA's otc stock performance is not an exact science, and many factors can impact Imerys SA's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Imerys OTC Stock analysis

When running Imerys SA's price analysis, check to measure Imerys SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imerys SA is operating at the current time. Most of Imerys SA's value examination focuses on studying past and present price action to predict the probability of Imerys SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imerys SA's price. Additionally, you may evaluate how the addition of Imerys SA to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years